| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |